Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year post image
Sustainability Pharmaceuticals Life Sciences Corporate Social Responsibility Awards ESG

WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year

by Newsdesk
Servier Acquires Potential Fragile X Syndrome Treatment KER-0193 post image
Pharmaceuticals Drug Development Neurology Fragile X Syndrome Autism Spectrum Disorder Rare Diseases Servier Acquisition fda

Servier Acquires Potential Fragile X Syndrome Treatment KER-0193

by Newsdesk
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder post image
Servier Fragile X Syndrome Autism Spectrum Disorder Neurology Pharmaceuticals Drug Acquisition Rare Diseases Clinical Trials

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

by Newsdesk
Servier Acquires Promising Treatment for Fragile X Syndrome post image
Fragile X Syndrome Autism Spectrum Disorder Neurology Pharmaceuticals Drug Development Rare Diseases Acquisition Servier fda

Servier Acquires Promising Treatment for Fragile X Syndrome

Featured post
by Newsdesk
Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald post image
Biotechnology Pharmaceuticals Stock Market Investment Analysis Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald

by Newsdesk
BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook post image
Biotechnology Pharmaceuticals Stock Market Investment Institutional Investors Market Analysis

BioMarin Pharmaceutical Attracts New Institutional Investment Amidst Positive Analyst Outlook

Featured post
by Newsdesk
Amanta Healthcare's Market Debut: IPO Expectations and Expansion Plans post image
Healthcare Pharmaceuticals IPO Stock Market Business News

Amanta Healthcare's Market Debut: IPO Expectations and Expansion Plans

by Newsdesk
Thai Hospitals Unite in Breakthrough Cancer Therapies post image
Healthcare Cancer Treatment Medical Innovation Thailand Cell and Gene Therapy

Thai Hospitals Unite in Breakthrough Cancer Therapies

Featured post
by Newsdesk
BioMarin Announces Positive Phase 3 Data for PALYNZIQ in Adolescent PKU Treatment post image
Pharmaceuticals Clinical Trials Rare Diseases Phenylketonuria (PKU) Adolescent Health

BioMarin Announces Positive Phase 3 Data for PALYNZIQ in Adolescent PKU Treatment

Featured post
by Newsdesk
Eli Lilly's Oral Weight-Loss Pill Orforglipron Nears Market, Offering Needle-Free Alternative post image
Pharmaceuticals Weight Loss Obesity Eli Lilly Orforglipron GLP-1 Agonists Medical Innovation Public Health

Eli Lilly's Oral Weight-Loss Pill Orforglipron Nears Market, Offering Needle-Free Alternative

Featured post
by Newsdesk
Mumbai Man Loses Rs 1.6 Crore in Alleged Pharmaceutical Venture Scam post image
pharma-industry business earnings

Mumbai Man Loses Rs 1.6 Crore in Alleged Pharmaceutical Venture Scam

Featured post
by Newsdesk
Reform UK Speaker's Covid Vaccine Claims Spark Controversy post image
pharma-industry business earnings

Reform UK Speaker's Covid Vaccine Claims Spark Controversy

Featured post
by Newsdesk